Dataset Information


Generating Peripheral Blood Derived Lymphocytes Reacting Against Autologous Primary AML Blasts.

ABSTRACT: Expanding on our prior studies with cord blood T cells, we hypothesized that primary acute myeloid leukemia (AML)-reactive autologous T cells could be generated ex vivo under immunomodulatory conditions. We purified AML and T cells from 8 newly diagnosed high-risk patients. After 2 weeks expansion, T cells were stimulated with interferon-?-treated autologous AML weekly × 3, interleukin-15, and agonistic anti-CD28 antibody. Cytotoxic T cells and ELISpot assays tested functionality; reverse transcriptase quantitative polymerase chain reaction tested AML and T-cell gene expression profiles. On the basis of combined positive ELIspot and cytotoxic T cells assays, T cells reactive against AML were generated in 5 of 8 patients. Treg proportion declined after cocultures in reactive T-cell samples. AML-reactive T cells displayed an activated gene expression profile. "Resistant" AML blasts displayed genes associated with immunosuppressive myeloid-derived suppressor cells. We discuss our approach to creating primary AML-reactive autologous T cell and limitations that require further work. Our study provides a platform for future research targeting on generating autologous leukemia-reactive T cells.


PROVIDER: S-EPMC4746019 | BioStudies | 2016-01-01

REPOSITORIES: biostudies

Similar Datasets

2018-01-01 | S-EPMC6129592 | BioStudies
2018-01-01 | S-EPMC6278634 | BioStudies
2010-01-01 | S-EPMC3032293 | BioStudies
1000-01-01 | S-EPMC5464808 | BioStudies
1000-01-01 | S-EPMC4630967 | BioStudies
2019-01-01 | S-EPMC6900505 | BioStudies
1000-01-01 | S-EPMC4691325 | BioStudies
1000-01-01 | S-EPMC4648523 | BioStudies
1000-01-01 | S-EPMC2945474 | BioStudies
2014-01-01 | S-EPMC4280064 | BioStudies